References
- Wei N, Kresch M, Elbogen E, Lebwohl M. New onset and exacerbation of psoriasis after COVID-19 vaccination. JAAD Case Rep. 2022; 19: 74–77. doi: 10.1016/j.jdcr.2021.11.016
- Tachibana K, Kawakami Y, Tokuda M, Sato S, Sugihara S, Miyake T, et al. Flare-up of generalized pustular psoriasis following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: two cases without mutations of IL36RN and CARD14 genes. J Dermatol. 2022. doi: 10.1111/1346-8138.16442
- McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after moderna and pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021; 85 (1): 46–55. doi: 10.1016/j.jaad.2021.03.092
- Huang YW, Tsai TF. Exacerbation of psoriasis FOLLowing COVID-19 vaccination: report from a single center. Front Med-Lausanne. 2021. doi:10.3389/fmed.2021.812010
- Perna D, Jones J, Schadt CR. Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine. JAAD Case Rep. 2021; 17: 1–3. doi: 10.1016/j.jdcr.2021.08.035
- Ouni N, Korbi M, Chahed F, et al. New-onset guttate psoriasis following coronavirus disease 2019 vaccination: about two cases. Dermatol Ther. 2022:15617. doi:10.1111/dth.15617
- Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017; 140 (3): 645–653. doi: 10.1016/j.jaci.2017.07.004
- Tran TNA, Nguyen TTP, Pham NN, Pham NTU, Vu TTP, Nguyen HT. New onset of psoriasis following COVID-19 vaccination. Dermatol Ther. 2022; e15590. doi: 10.1111/dth.15590
- Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor fedratinib. J Microbiol Immunol Infect. 2020; 53 (3): 368–370. doi: 10.1016/j.jmii.2020.03.005